Georgia Rx association tackles compounding
By HME News Staff
Updated Tue September 30, 2003
CONYERS, Ga. -  The Georgia Pharmacy Association got proactive in late
August and created a committee to focus on compounding, which has become a highly charged topic among regulators and lawmakers.
The committee doesn't have a name but its duties are multifold: study legislative issues related to compounding and lobby when necessary; assist members with continuing education; educate doctors and other healthcare professionals about compounding.
Federal interest in the compounding procedure escalated in late June when Sens. Kit Bond (R-Mo.) and Pat Roberts (R-Kan.) announced intentions to investigate the safety of drug compounding at the pharmacy level. Recent incidents of cancer drug dilution and bacteria contamination that resulted in patient deaths prompted the senators to create an advisory committee to study the safety and necessity of compounded drugs.
Rather than sit back and watch lawmakers and regulators propose and possibly enact uniformed legislation, the Georgia Pharmacy Association decided to educate them, as well as other healthcare professionals, about the benefits and the need for compounding, said committee member Jeff Reagan, owner of Reagan Home Care Pharmacy.
Comments